Cargando…
The Effects of Helicobacter Pylori Eradication on Liver Function and Metabolic Profile in Non-diabetic Non-alcoholic Steatohepatitis: A 5-year Randomized Clinical Trial
BACKGROUND: To evaluate the effects of Helicobacter pylori (HP) eradication on liver function tests (LFT) and fat content (LFC) in non-diabetic non-alcoholic steatohepatitis (NASH). METHODS: This randomized clinical trial included dyspeptic HP infected non-diabetic NASH participants. The interventio...
Autores principales: | Jamali, Arsia, Karbalai, Shahrokh, Tefagh, Ghazale, Jamali, Raika, Ahmadi, Ayat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Association of Gastroerterology and Hepatology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489323/ https://www.ncbi.nlm.nih.gov/pubmed/36619724 http://dx.doi.org/10.34172/mejdd.2022.260 |
Ejemplares similares
-
The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Subjects With Non-Alcoholic Fatty Liver Disease: A Randomized Open-Label Clinical Trial
por: Jamali, Raika, et al.
Publicado: (2013) -
The Correlation between Serum Zinc Level and Liver Histology in Non-Alcoholic Steatohepatitis
por: Kosari, Farid, et al.
Publicado: (2019) -
Which Metabolic Index is Appropriate for Predicting Non-alcoholic Steatohepatitis?
por: Jamali, Raika, et al.
Publicado: (2020) -
Liver fat content might be an appropriate measure for estimation of cardiovascular disease risk in non-alcoholic steatohepatitis patients
por: Jamali, Raika, et al.
Publicado: (2020) -
The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease
por: Jamali, Raika, et al.
Publicado: (2016)